Pierre Legault has served as a member of our board of directors since July 2018 and as our Lead Independent Director since December 2019. Mr. Legault also currently serves as board director and chairman of Poxel SA, Bicycles Therapeutics Inc., Amolyt Pharmaceuticals Inc, and Artios Pharma Limited. Mr. Legault also serves as a board director of Syndax Pharmaceuticals Inc. Previously, Mr. Legault served as a member of the boards of directors at Forest Laboratories, Inc., Clementia Pharmaceuticals Inc., Tobira Therapeutics, Inc., NPS Pharmaceuticals, Inc., Regado Biosciences, Inc., ARMO Biosciences, Iroko Pharmaceuticals LLC, Cyclacel Pharmaceuticals Inc., Eckerd Pharmacy and NephroGenex, Inc., where he also served as the Chairman and Chief Executive Officer. From 2010 to 2012, Mr. Legault served as the Chief Executive Officer of Prosidion Ltd., a subsidiary of Astellas, and he served as the Chief Financial Officer and Treasurer of OSI Pharmaceuticals, Inc from 2009 to 2010. Mr. Legault also previously served as the President of Eckerd Pharmacy and Senior Executive Vice President and Chief Administrative Officer of the Rite Aid Corporation. Between 1989 and 2005, Mr. Legault held various global roles such as President, Chief Executive Officer and Chief Financial Officer at legacy companies of the Sanofi-Aventis group. Mr. Legault earned a B.B.A. in Business & International Finance from HEC Montreal, an M.B.A. in Marketing from McGill University and holds C.A. and C.P.A. diplomas. He also studied at Harvard Business School in their Graduate Executive MBA program.